Professor Jo Lambert

President

Jo Lambert is a Senior Full Professor in Dermatology and Venereology, and chairing the Department of Dermatology at Ghent University, Ghent, Belgium. She is current chair of the EADV Task Force Psoriasis, Councilor International Psoriasis Council. And Associate Editor of JEADV.

She specialises in the fields of immune dermatoses. Her research interests lie in the improvement of care in immune-mediated inflammatory skin disorders: from advanced models of topical drug delivery to personalised dosing of biologicals. She founded the DermPlus approach, an example of a value-based integrated practice unit for immune-mediated chronic skin diseases. She is member of the Belgian Royal Academy of Medicine. She has 288 publications, 6980 sum of times cited, and an H-index of 46.

Professor Joel M. Gelfand

President-elect

Joel M. Gelfand MD MSCE is the James J. Leyden Endowed Professor of Clinical Investigation, and Professor (with tenure) of Dermatology and Epidemiology, Director (co-founding) of the Center for Clinical Sciences in Dermatology, and Director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine. He is an internationally recognized expert in psoriasis, epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 330 scientific publications cited over 43,000 times (H index 103). His research program was the first to establish that psoriasis patients have an increased risk of cardiovascular disease and mortality. He conducts patient centered research through the Dermatology Clinical Effectiveness Research Network (DCERN), which he founded in 2009 and involves over 50 dermatology practices in the US. He has received investigator-initiated research grants from NIH, FDA, PCORI, Foundations, and industry. He has given over 10 named lectureships and keynote addresses including the SID ’s Eugene M. Farber lecture and the AAD’s Marion B. Sulzberger lecture. He is the recipient of the American College of Epidemiology 2023 Outstanding Contributions Award, the American Skin Association’s Psoriasis Achievement Award, the Lady Barbara Colyton’s Award for Autoimmune research, the National Psoriasis Foundation’s lifetime achievement award, the American Dermatoepidemiology Network’s Founders award, and is an elected member of the American Society for Clinical Investigation. He is a member of the Board of Directors for the International Psoriasis Council and the Medical Dermatology Society.

Vinod Chandran

Co-chair Rheumatology

Vinod Chandran MBBS, MD, DM, PhD, FRCPC, a rheumatologist, is a clinician scientist at the Schroeder Arthritis, University Health Network (UHN), Professor of Medicine at the University of Toronto and holds the Dr. Dafna D. Gladman Chair in Psoriatic Arthritis Research at UHN. He is an expert in psoriatic arthritis and directs the Gladman Krembil Psoriatic Arthritis Program at the Schroeder Arthritis Institute. His translational research program is focused on developing biomarker-based diagnostic and prognostic tools for psoriatic arthritis, with support by grants from the Canadian Institutes of Health Research, the National Psoriasis Foundation, the Arthritis Society, and the Krembil Foundation. He has published more than 250 papers. He is an elected member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA- an international organization facilitating research and education on the management of psoriasis and psoriatic arthritis) Board of Directors and its Co-Vice President.